
Failure of Chloroquine Treatment to Prevent Malaria in Americans in West Africa
John S. Moran, MD
Peace Corps Washington, DC
Kenneth W. Bernard, MD;
Alan E. Greenberg, MD
Leslie Patchen Centers for Disease Control Atlanta
Sheila Waterman, RN;
H. Stanley Bennett, MD
Peace Corps Lome, Togo
JAMA. 1987;258(17):2376-2377.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
Since chloroquineresistant falciparum (CRPF) malaria was first reported in Africa in 1978,1 it has spread steadily westward and is now well established in coastal Benin.2 Confirmed reports of CRPF malaria west of Benin are limited to a single case in Ghana3 and reports of decreased sensitivity to chloroquine therapy in patients with Plasmodium falciparum from Gambia4 and Senegal.5 A study of Togolese children in 1985 showed that administration of 10 mg/kg of chloroquine base was highly effective in eliminating parasites from the blood.6 We now report five cases of P falciparum among expatriates in Togo who had taken regular chloroquine prophylaxis (300 mg of base per week).
Study.—
The five patients were American Peace Corps volunteers (PCVs) between the ages of 20 and 40 years who had been living in Togo for more than six months. None had traveled to
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|